ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1568

Existence of IL-6 and IL-17 Mediated Inflammation Amplifier Loop in Reactive Arthritis

Ramnath Misra1, Sandeep Kumar2, Rajeev Singh3, Abhisek Singh4, Daisuke Kamimura5, Smriti Chaurasia2, Yasunobu Aria6, Tori Austria7, Ratnadeep Mukherjee8, Balachandran Ravindran9, Vikas Agarwal2 and Masaaki Murakami10, 1Clinical Immunology, Sanjay Gandhi Postgraduate of Medical Sciences, Lucknow, India, 2Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, 3Biochemistry, King George Medical University, Lucknow, India, 4Division of Molecular Neroimmunology, Post Doctoral Fellow, Sapporo, Japan, 5Molecular Neuroimmunology, Lecturer, Sapporo 060-0815,, Japan, 6Division of Molecular Neuroimmunology, Assistant Professor, Sapporo 060-0815, Japan, 7Division of Molecular Neuroimmunology, Special appointed - Assistant Professor, Sapporo 060-0815, Japan, 8Institute of Life Sciences, Ph D student, Bhubaneswar, India, 9Institute of Life Sciences, Distinguished Scientist, Bhubaneswar, India, 10Institute of Genetic Medicine, Director, Sapporo 060-0815, Japan

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: IL-6R signaling, Inflammation, inflammatory cytokines, mouse model and reactive arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Spondyloarthropathies and Psoriatic Arthritis – Pathogenesis, Etiology Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: F759 mice with a single amino-acid substitution in signal transducer subunit of IL-6 receptor gp130 (Y759F) develops arthritisspontaneously due to IL-17A and IL-6 mediated synergistic activation of positive-feedback loop of NF-kB signaling (inflammation amplifier).We sought to see whether this mechanism is operational in Reactive arthritis.

Methods: Arthritis was induced with oral feeding of salmonella enterica followed by ankle microbleeding in the ankle joints of F759 mice. Sera IL-6 along with IL-6 mRNA and STAT3 phosphorylation in synovium were measured. Further,exosomes isolated from sera of salmonella infected and control mice and were injected into the joints of mice, and measured the expression of proinflammatory cytokine, chemokines and growth factor. On the other hand, sera and synovial fluid of patients with ReA multiple cytokines, chemokines and growth factors were also measured. Finally, synovial fibroblasts (FLS) were cultured to purity and stimulated with IL-6, IL-17, IL-6 plus IL-17 and IL-6 were measured to see synergistic activation.

Results: IL-6 in sera of arthritic mice were significantly higher (p<0.05) than control mice along with increase STAT3 phophorylation in the synovium. Though, oral infection itself not sufficient to induce arthritis but if infection is followed by microbleeding then it significantly induces the arthritis in these mice (Fig-1). Further, exosomes from salmonella infected mice induced arthritis in ankle joint and significantly increased IL-6 expression (p<0.05). Similarly, in comparison to IL-6 and IL-17 alone these cytokines synergistically induced more IL-6 production from FLS isolated from ReA patients (Fig-2). Finally, we found that SF concentrations of effectors of inflammation amplifiers like IL-6, CCL-20, PLGF and FGF-basic were significantly higher in patients with ReA/uSpA as compared to osteoarthritis patients. Further, levels of these factors were also high in SF compared to sera in ReA patients.

Conclusion: Data of mice and patients support that synovitis in ReA is perpetuated by inflammation amplifier or synergistic induction of IL-6 and IL-17.

Figure 1: Oral infection of Salmonella followed by microbleeding into the ankle joint induces clinical symptoms of arthritis.

  

Figure 2: Activation of FLS isolated from ReA patients with IL-6 and IL-17 alone and synergistically with both cytokines and measurement of IL-6 level in culture supernatant.


Disclosure: R. Misra, None; S. Kumar, None; R. Singh, None; A. Singh, None; D. Kamimura, None; S. Chaurasia, None; Y. Aria, None; T. Austria, None; R. Mukherjee, None; B. Ravindran, None; V. Agarwal, None; M. Murakami, None.

To cite this abstract in AMA style:

Misra R, Kumar S, Singh R, Singh A, Kamimura D, Chaurasia S, Aria Y, Austria T, Mukherjee R, Ravindran B, Agarwal V, Murakami M. Existence of IL-6 and IL-17 Mediated Inflammation Amplifier Loop in Reactive Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/existence-of-il-6-and-il-17-mediated-inflammation-amplifier-loop-in-reactive-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/existence-of-il-6-and-il-17-mediated-inflammation-amplifier-loop-in-reactive-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology